Loading...
Thumbnail Image
Publication

Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes

Nwosu, Benjamin U.
Yeasmin, Shamima
Ayyoub, Sanaa S.
Rupendu, Shwetha
Villalobos-Ortiz, Tony R.
Jasmin, Gabrielle
Parajuli, Sadichchha
Zahedi, Bita
Zitek-Morrison, Emily
Alonso, Laura C.
... show 1 more
Embargo Expiration Date
Link to Full Text
Abstract

Background:

Physiologic hyperglycemia of puberty is a major contributor to poor glycemic control in youth with type 1 diabetes (T1D). This study's aim was to determine the effectiveness of continuous glucose monitoring (CGM) to improve glycemic control in pubertal youth with T1D compared to a non-CGM cohort after controlling for age, sex, BMI, duration, and insulin delivery methodology. The hypothesis is that consistent CGM use in puberty improves compliance with diabetes management, leading to increased percentage (%) time in range (TIR70-180 mg/dL) of glycemia, and lowering of HbA1c.

Methods

A longitudinal, retrospective, case-controlled study of 105 subjects consisting of 51 T1D controls (60.8% male) age 11.5 +/- 3.8 y; and 54 T1D subjects (48.1% male) age 11.1 +/- 5.0 y with confirmed CGM use for 12 months. Pubertal status was determined by Tanner staging. Results were adjusted for baseline HbA1c and diabetes duration.

Results

HbA1c was similar between the controls and the CGM group at baseline: 8.2 +/- 1.1% vs 8.3 +/- 1.2%, p=0.48 respectively; but was significantly lower in the CGM group 12 months later, 8.2 +/- 1.1% vs. 8.7 +/- 1.4%, p=0.035. Longitudinal change in HbA1c was similar in the prepubertal cohort between the control- and CGM groups: -0.17 +/- 0.98% vs. 0.38 +/- 1.5%, p=0.17. In contrast, HbA1c increased with advancing age and pubertal status in the pubertal controls but not in the pubertal CGM group: 0.55 +/- 1.4 vs -0.22 +/- 1.1%, p=0.020. Percent TIR was inversely related to HbA1c in the CGM group, r=-0.6, p=0.0004, for both prepubertal and pubertal subjects.

Conclusions

CGM use significantly improved glycemic control in pubertal youth with T1D compared to non-CGM users.

Source

Nwosu BU, Yeasmin S, Ayyoub S, Rupendu S, Villalobos-Ortiz TR, Jasmin G, Parajuli S, Zahedi B, Zitek-Morrison E, Alonso LC, Barton BA. Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes. J Pediatr Endocrinol Metab. 2020 Jul 28;33(7):865-872. doi: 10.1515/jpem-2020-0057. PMID: 32634109. Link to article on publisher's site

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1515/jpem-2020-0057
PubMed ID
32634109
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
© Walter de Gruyter GmbH 2020. Publisher PDF posted after a 12-month embargo as allowed by the publisher's copyright transfer agreement at https://www.degruyter.com/page/2301. The final publication is available at www.degruyter.com.
Distribution License